Abstract:BACKGROUND:Primary and metastatic cancers that affect bone are frequently associated with severe and intractable pain. The mechanisms underlying the development of bone cancer pain are largely unknown. The aim of this study was to determine whether enhanced excitability of primary sensory neurons contributed to peripheral sensitization and tumor-induced hyperalgesia during cancer condition. In this study, using techniques of whole-cell patch-clamp recording associated with immunofluorescent staining, single-cell reverse-transcriptase PCR and behavioral test, we investigated whether the intrinsic membrane properties and the excitability of small-sized dorsal root ganglion (DRG) neurons altered in a rat model of bone cancer pain, and whether suppression of DRG neurons activity inhibited the bone cancer-induced pain.RESULTS:Our present study showed that implantation of MRMT-1 tumor cells into the tibial canal in rats produced significant mechanical and thermal hyperalgesia in the ipsilateral hind paw. Moreover, implantation of tumor cells provoked spontaneous discharges and tonic excitatory discharges evoked by a depolarizing current pulse in small-sized DRG neurons. In line with these findings, alterations in intrinsic membrane properties that reflect the enhanced neuronal excitability were observed in small DRG neurons in bone cancer rats, of which including: 1) depolarized resting membrane potential (RMP); 2) decreased input resistance (Rin); 3) a marked reduction in current threshold (CT) and voltage threshold (TP) of action potential (AP); 4) a dramatic decrease in amplitude, overshot, and duration of evoked action potentials as well as in amplitude and duration of afterhyperpolarization (AHP); and 5) a significant increase in the firing frequency of evoked action potentials. Here, the decreased AP threshold and increased firing frequency of evoked action potentials implicate the occurrence of hyperexcitability in small-sized DRG neurons in bone cancer rats. In addiotion, immunofluorescent staining and single-cell reverse-transcriptase PCR revealed that in isolated small DRG neurons, most neurons were IB4-positive, or expressed TRPV1 or CGRP, indicating that most recorded small DRG neurons were nociceptive neurons. Finally, using in vivo behavioral test, we found that blockade of DRG neurons activity by TTX inhibited the tumor-evoked mechanical allodynia and thermal hyperalgesia in bone cancer rats, implicating that the enhanced excitability of primary sensory neurons underlied the development of bone cancer pain.CONCLUSIONS:Our present results suggest that implantation of tumor cells into the tibial canal in rats induces an enhanced excitability of small-sized DRG neurons that is probably as results of alterations in intrinsic electrogenic properties of these neurons. Therefore, alterations in intrinsic membrane properties associated with the hyperexcitability of primary sensory neurons likely contribute to the peripheral sensitization and tumor-induced hyperalgesia under cancer condition.

Cancer–nerve interplay in cancer progression and cancer-induced bone pain

Peripheral Mechanism of Cancer-Induced Bone Pain.

Neurophysiological mechanisms of cancer-induced bone pain

New Insights of Nociceptor Sensitization in Bone Cancer Pain.

Crosstalk between bone metastatic cancer cells and sensory nerves in bone metastatic progression

Cnsc-13. Crosstalk Between Sensory Neuronal Activity And Tumor Cells Promotes Malignancy And Cancer Pain

Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications

Cancer aggravation due to persistent pain signals with the increased expression of pain-related mediators in sensory neurons of tumor-bearing mice

Cancer-induced Bone Pain: Spinal Cord Mechanisms and Traditional Chinese Medicine Treatment

A Mouse Model of Cancer Induced Bone Pain: From Pain to Movement

P2Y12 Receptor-Mediated Activation of Spinal Microglia and P38mapk Pathway Contribute to Cancer-Induced Bone Pain

From pain to tumor immunity: influence of peripheral sensory neurons in cancer

Enhanced Excitability of Small Dorsal Root Ganglion Neurons in Rats with Bone Cancer Pain.

Decreased sensory nerve excitation and bone pain associated with mouse Lewis lung cancer in TRPV1-deficient mice

Contribution of immune cells to cancer-related neuropathic pain: An updated review

The Nonreceptor Protein Tyrosine Kinase Src Participates in Every Step of Cancer-Induced Bone Pain

The Potential Therapeutic Targets to Bone Pain Induced by Cancer Metastasis

Perineural invasion: a potential driver of cancer-induced pain.

Molecular mechanisms of cancer pain

Nuclear Factor Kappa B Regulated Monocyte Chemoattractant Protein-1/Chemokine CC Motif Receptor-2 Expressing in Spinal Cord Contributes to the Maintenance of Cancer-Induced Bone Pain in Rats.

Blocking Cancer-Nerve Crosstalk for Treatment of Metastatic Bone Cancer Pain.